Parasite Replication Is Rapid during the Acute Phase of Infection
Humans become infected with Toxoplasma by consuming undercooked, cyst-containing meat, while animals become infected through predation ( Fig. 1) . Within the small intestine, parasites emerge as tachyzoites, actively invading cells of the intestinal mucosa in a process involving sequential discharge of apically oriented organelles called micronemes and rhoptries. Early after invasion, the parasitophorous vacuole is established, a membrane-bound structure within which tachyzoites replicate until the host cell lyses and infectious organisms are released.
During this acute stage of infection, Toxoplasma widely disseminates through host tissues, typically causing mild flulike symptoms. As the host adaptive immune system begins to respond, the parasites differentiate into slow-growing bradyzoites that form cysts in tissues of the muscle and central nervous system. During this longlived stage of the parasite, cysts are maintained in tissues with little or no host inflammatory reaction.
Yet, for individuals with declining immunity such as those with AIDS, toxoplasmosis is a lifethreatening infection. Parasite cysts within the brains of such individuals may reactivate, with bradyzoites redifferentiating into tissue-damaging tachyzoites. Ensuing toxoplasmic encephalitis can be lethal in the absence of appropriate drug treatment.
Domestic and wild cats, members of the family Felidae, are the defınitive hosts of Toxoplasma. When cats prey on infected animals, ingested parasites reproduce sexually within the small intestines of their hosts. Subsequent fecal shedding distributes large numbers of highly infectious oocysts, which are readily ingested to continue the life cycle of this parasite in intermediate hosts.
However, Toxoplasma can also be orally transmitted directly from one intermediate host to the next, meaning passage through cats is not oblig-atory. This feature of Toxoplasma might be a recent adaptation that helps to account for the global distribution of this parasite.
Encounter with the Host Immune System
T. gondii withstands challenges from both the innate and acquired arms of the host immune system. Simply evading the immune system could lead to uncontrolled replication and death for both the parasite and host. For example, when immunodefıcient mice that cannot produce interferon-␥ (IFN-␥) are infected with Toxoplasma, the parasite spreads rampantly, leading the host to die rapidly. Thus, the host needs to mount a Th1 response if the parasite is to develop a latent infection.
At the other extreme, a very robust immune response eliminates the parasite, but may lead to proinflammatory tissue damage that can be lethal for the host. For example, mice lacking the downregulatory cytokine interleukin-10 (IL-10) succumb to Toxoplasma much as do mice that are defıcient in IFN-␥. However, in this case, death is attributed to unchecked production of proinflammatory cytokines such IFN-␥ and tumor necrosis factor-␣ (TNF-␣). Because latent T. gondii infection is widespread throughout the vertebrate animal kingdom, this suggests that this parasite is adept at balancing immune activation against evasion.
We discovered a striking example of Toxoplasma-directed evasion of immunity several years ago. Macrophages, which along with dendritic cells are targets of in vivo infection, produce cytokines such as TNF-␣ and IL-12 when activated through Toll-like receptors on the cell surface. Yet, if these cells are fırst exposed to tachyzoites, they lose their ability to respond and TNF-␣ production is suppressed. They also lose their ability to respond to IFN-␥. Because other mediators such as anti-inflammatory IL-10 are unaffected, carrying Toxoplasma does not make such cells generally dysfunctional (Fig. 2) . Moreover, only cells containing intracellular parasites become nonresponsive. In other words, there is no bystander effect on uninfected cells. Instead, Toxoplasma directly subverts these signaling pathways within host cells.
Highjacking the JAK/STAT Pathway
T. gondii affects host macrophages much like IL-10, an anti-inflammatory cytokine that strongly down-regulates macrophage production of TNF-␣ and IL-12. However, it is unlikely that IL-10 is the cause of Toxoplasma-mediated suppression, because only infected cells are affected. Indeed, macrophages generated from IL-10 knockout mice retain sensitivity to the inhibitory effects of the parasite.
T. gondii instead bypasses IL-10 and directly activates anti-inflammatory signaling. Like many cytokines, IL-10 depends on a Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling. In the canonical JAK/STAT pathway (Fig. 3) , cytokine binding to its receptor leads that receptor to form dimers. In turn, cytoplasmic STAT molecules undergo JAKdependent tyrosine phosphorylation, leading STAT molecules to form dimers, translocate to the nucleus, and bind to STAT-responsive promoters. In many cases, full transcriptional activity requires STAT serine phosphorylation dependent upon mitogen-activated protein kinase (MAPK) signaling. Specifıcity in cytokine-mediated signaling comes from differential involvement of multiple JAK molecules (JAK1, JAK2, JAK3, TYK2) and multiple STAT proteins (STAT1, 2, 3, 4, 5a, 5b, 6) that form various cytokine-dependent complexes.
Interleukin 
Parasite Secretory Kinases Interact with Host Cell Signaling
T. gondii isolates from Europe and North America largely fall into three clonal lineages. In mice, Type I is extremely virulent, Type II is intermediate, and Type III has low virulence. These strains emerged from genetic crosses roughly 10,000 years ago, which coincides with when humans began domesticating animals. During that period, animal species such as cats and rodents came into close contact with one another and humans-all of which likely increased the frequency of sexual reproduction among Toxoplasma strains.
These three types of T. gondii strains also differ in terms of the immune responses they elicit. For example, Type II parasites induce relatively high amounts of IL-12 and activate NFB, whereas Type I stains induce only low amounts of IL-12 and no activity in the NFB pathway. By analyzing F 1 progeny from interstrain crosses, John Boothroyd at Stanford and David Sibley at Washington University identifıed the rop16 virulence locus and, later, linked it to activation of STAT3 and STAT6. Thus, Type I and Type III strains possess a ROP16 allele that activates STAT3 and The rop16 locus encodes the rhoptry protein ROP16, which with other rhoptry proteins, is injected into the host cell cytoplasm as the parasite invades. Some of these proteins are found along the parasitophorous vacuole membrane, others are cytoplasmic.
ROP16 provides the fırst concrete example of an effector molecule from an intracellular eukaryote that targets host signal transduction machinery-in this case, JAK/STAT signaling. Thus, Type I ROP16 is a kinase that directly phosphorylates tyrosine and can activate STAT3 and STAT6, according to John Boothroyd of Stanford University and M. Yamamoto and T. Takeda of Osaka University in Osaka, Japan. Shortly after being injected into the cytosol, at least some of ROP16 traffıcs to the host cell nucleus, even though STAT is activated in the host cell cytoplasm. Why ROP16 moves to the host cell nucleus remains a mystery.
Biological Function of the ROP16 Secretory Kinase
David Bzik and Barbara Fox at Dartmouth Medical School constructed mutants of Type I parasites in which the ROP16 molecule is deleted. Working with these and other mutants, we showed that tachyzoites survive and replicate in the absence of ROP16. Yet, the extent to which ROP16 alleles contribute to differences between high and low virulence strains of these parasites during in vivo infections is not fully explored. Regardless, because ROP16 activates both STAT3 and STAT6 -two distinct transcription factors with distinct activities-the functions of this rhoptry kinase are likely to be multifarious.
The STAT3 transcription factor is complex, capable of activating an IL-6-mediated proinflammatory profıle. Opposing this, the anti-inflammatory effects of IL-10 are also mediated through a STAT3 activation pathway. The molecular switch that determines whether STAT3 is pro-inflammatory or anti-inflammatory seems to be the molecular suppressor of cytokine synthesis (SOCS)-3, because IL-6 signals an antiinflammatory transcription program in its absence. Toxoplasma-activated STAT3 seems to have anti-inflammatory effects similar to those of IL-10 (Fig. 4) .
Activating STAT6 in macrophages leads to an alternatively activated (or M2) phenotype. Such M2 macrophages likely help to repair tissues, relying in part on elevated arginase-1 to convert arginine to ornithine, a precursor of polyamines and collagen. By contrast, IFN-␥ and lipopolysaccharide induce M1 macrophages, which function as antimicrobial effector cells, producing nitric oxide and other antimicrobial agents. Parasitemediated STAT3 activation is expected to antagonize M1 macrophage function, while STAT6 activation would directly promote M2 macrophages during Type I infections.
STAT3 and STAT6 phosphorylation by T. gondii strains I and III versus lack of activation of these same transcription factors by Type II parasites may all serve the same end, namely persistence and transmission (Fig. 4) . Type I parasites activating STAT3 via ROP16 may modulate proinflammatory cytokines, thereby evading immunity and establishing an infection.
By activating STAT6 and inducing arginase-1, Type I parasites limit arginine within host cells, possibly avoiding the effects of nitric oxide, whose synthesis depends on arginine. Because Toxoplasma is an arginine auxotroph, inducing arginase-1 likely also slows parasite replication, better enabling T. gondii to disseminate within its host. Our evidence suggests that deleting ROP16 increases replication of Type I parasites. However, arginase-1 promotes polyamine production, which the parasite requires as a source of amino acids. According to Jeroen Saeij of Massachusetts Institute of Technology, STAT6-dependent arginase-1 promotes parasite growth, speeding cycles of replication and host cell lysis. For Toxoplasma Type II strains, failure to activate STAT3 and increased proinflammatory mediators may stimulate enough of an immune response to allow the host to survive. Absence of STAT6 phosphorylation could increase arginine and facilitate parasite replication. Alternatively, lack of arginase-1 could decrease polyamines, acting to limit parasite replication. What predominates in any particular host cell likely depends on cell type and stage of infection.
Recent phylogenomic studies indicate that ROP16 is a member of a rhoptry kinase family of up to 40 genes whose function is largely unexplored. With the work on ROP16 we have only scratched the surface, and it seems certain that the years to come will bring deeper insights into how this intracellular protozoan employs its arsenal of rhoptry proteins to leverage survival in host cells.
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